Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with coronary heart disease where full restoration of blood flow to the heart was not completed, based on imaging showing at least one significantly blocked artery (confirm with trial site for specific measurement details)
- People who have symptoms of reduced blood flow to the heart, such as chest pain at rest or during activity, chest tightness, or shortness of breath
Who may not be able to join:
- People under 18 years of age
- People with severe heart failure (classified as the most serious level, known as NYHA class IV), or whose heart is pumping at very low capacity
- People with severely reduced kidney function or who require dialysis
- People with certain heart muscle diseases, such as an abnormally thick or enlarged heart muscle
- People with uncontrolled or repeatedly occurring dangerous heart rhythm problems that have not responded to treatment
- People with very poorly controlled high blood pressure despite treatment
- People with active liver disease or significantly elevated liver enzyme levels in blood tests
- People with significantly elevated muscle enzyme levels in blood tests, or a known muscle disease causing such elevations
- People who have planned heart surgery or a procedure to restore blood flow scheduled before the trial begins
- People who have had an active cancer diagnosis requiring treatment within the past three years
- People with diagnosed or suspected abnormalities, bulging, abnormal connections, or clotting in the blood vessels of the upper arms
- People with hearing impairment that would prevent participation in mindfulness-based therapy sessions
- People currently enrolled in another clinical study involving a drug or medical device, or who completed such a study or received an experimental treatment within the past 30 days
- People with a serious non-heart-related condition expected to be life-threatening within the next year
- People with a history of alcohol or substance misuse who are unwilling or unable to stop during the study
- People who have had a major organ transplant, such as a heart, lung, liver, kidney, or bone marrow transplant
- People with other serious, active, or uncontrolled medical conditions that the trial doctor believes could interfere with safe participation
- People who, in the trial doctor's judgement, are unlikely to complete follow-up visits over more than one year or are unlikely to be able to follow the study requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Muwei LI, MD, Fuwai Central China of Cardiovascular Hospital
Phone: 15670510031
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of MACE
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.